BEAM
Beam Therapeutics Inc
24.70$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,739.1% | -97.7% | +58.9% | +21.2% | +110.7% | -75.2% | +13.3% | +14.6% | +1,076.6% | -72.2% | -98.5% | – | |
| – | +40.0% | -39.4% | +2.6% | +8.3% | +7.6% | -2.6% | +3.0% | +7.9% | -94.8% | +95.1% | – | – | |
| – | – | -144.0% | – | – | – | – | – | – | – | -80.9% | -97.6% | – | |
| – | +40.0% | -39.4% | +2.6% | +8.3% | +7.6% | -2.6% | +3.0% | +7.9% | -9.6% | +5.3% | -9.0% | – | |
| – | +70.2% | -38.2% | +10.9% | -10.5% | +8.1% | -2.5% | -3.9% | -0.4% | -0.5% | +29.4% | -7.2% | – | |
| – | +70.2% | -38.2% | +10.9% | -10.5% | +8.1% | -2.5% | -3.9% | -0.4% | +370.8% | +1.6% | -0.7% | – | |
| – | – | -178.4% | – | – | – | – | – | – | – | – | – | – | |
| – | -5.0% | – | – | -14.5% | – | – | – | -11.5% | -2.4% | -7.3% | -24.1% | – | |
| – | – | -168.4% | – | – | – | – | – | – | – | -138.6% | – | – | |
| – | – | +294.4% | -99.3% | -14,138.5% | – | – | – | – | – | – | – | – | |
| – | – | -169.1% | – | – | – | – | – | – | – | -138.6% | – | – | |
| – | – | -162.4% | – | – | – | – | – | – | – | -134.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.